Eczema is a common skin condition that causes itchy, red, dry, and irritated skin. The type of eczema you have can determine what type of rash you develop and where on your body it occurs. Eczema is ...

A multi-agent clinical decision support system for dermatology that demonstrates diagnostic robustness under varying levels of clinical information. Built for the Med-Gemma Impact Challenge. The core ...

“2025 was another important year for Almirall as we continue to deliver against our sustained growth trajectory and further expand our leadership in medical dermatology. Another year of double-digit ...

The FDA has approved topical difamilast for treating mild-to-moderate atopic dermatitis (AD) in adults and children aged 2 years or older, according to a press release from the manufacturer, Acrotech ...

Clinically meaningful improvements in pruritus, skin nodules and lesions, sleep, and quality of life were associated with long-term nemolizumab use among patients with prurigo nodularis. Long-term use ...

For individuals living with eczema, a skin care routine centered on gentle, skin barrier-restoring products can help manage the symptoms brought on by a flare. “Eczema is a chronic inflammatory ...

Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate to severe atopic dermatitis after it failed to meet efficacy goals in an ...